Global Injectable Drugs Market Growth 2023-2029

Global Injectable Drugs Market Growth 2023-2029

Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.

LPI (LP Information)' newest research report, the “Injectable Drugs Industry Forecast” looks at past sales and reviews total world Injectable Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Injectable Drugs sales for 2023 through 2029. With Injectable Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Drugs industry.

This Insight Report provides a comprehensive analysis of the global Injectable Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Injectable Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Drugs and breaks down the forecast by packaging type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Drugs.

The global Injectable Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Drugs market by product packaging type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by packaging type
Ampoules
Vials
Cartridges
Bottles

Segmentation by application
Hospital
Clinic
Home Care
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Sanofi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Injectable Drugs market?

What factors are driving Injectable Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Injectable Drugs market opportunities vary by end market size?

How does Injectable Drugs break out packaging type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.